Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15 ...

Shares of Thermo Fisher Scientific Inc. TMO rallied 1.47% to $427.53 Tuesday, on what proved to be an all-around positive ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Read why I ...

Thermo Fisher Scientific (TMO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...

Thermo Fisher Scientific Inc. provides life sciences ... Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug ...